Login / Signup

Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.

Thiago Domingos CorreaGustavo Faissol Janot de MatosBruno de Arruda BravimRicardo Luiz CordioliAlejandra Del Pilar Gallardo GarridoMurillo Santucci César de AssunçãoCarmen Silvia Valente BarbasKarina Tavares TimenetskyRoseny Dos Reis RodriguesHélio Penna GuimarãesRoberto Rabello FilhoFrederico Polito LomarFarah Christina de La Cruz ScarinCarla Luciana BatistaAdriano José PereiraJoão Carlos de Campos GuerraBárbara Vieira CarneiroRicardo Kenji NawaRodrigo Martins BrandãoAntonio Eduardo Pereira PesaroMoacyr Silva JúniorFabrício Rodrigues Torres de CarvalhoCilene Saghabi de Medeiros SilvaAna Claudia Ferraz de AlmeidaMarcelo FrankenMarcele Liliane PesaventoRaquel Afonso Caserta EidLeonardo Jose Rolim Ferraz
Published in: Einstein (Sao Paulo, Brazil) (2020)
In December 2019, a series of patients with severe pneumonia were identified in Wuhan, Hubei province, China, who progressed to severe acute respiratory syndrome and acute respiratory distress syndrome. Subsequently, COVID-19 was attributed to a new betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 20% of patients diagnosed as COVID-19 develop severe forms of the disease, including acute hypoxemic respiratory failure, severe acute respiratory syndrome, acute respiratory distress syndrome and acute renal failure and require intensive care. There is no randomized controlled clinical trial addressing potential therapies for patients with confirmed COVID-19 infection at the time of publishing these treatment recommendations. Therefore, these recommendations are based predominantly on the opinion of experts (level C of recommendation).
Keyphrases